Literature DB >> 1848680

Preemptive therapy in immunocompromised hosts.

R H Rubin.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 1848680     DOI: 10.1056/NEJM199104113241509

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

1.  Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients.

Authors:  A M Caliendo; K St George; S Y Kao; J Allega; B H Tan; R LaFontaine; L Bui; C R Rinaldo
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Oral ganciclovir usage for cytomegalovirus prophylaxis in organ transplant recipients: is emergence of resistance imminent?

Authors:  N Singh; V L Yu
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

3.  Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors.

Authors:  P Grossi; S Kusne; C Rinaldo; K St George; M Magnone; J Rakela; J Fung; T E Starzl
Journal:  Transplantation       Date:  1996-06-15       Impact factor: 4.939

Review 4.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

5.  Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification.

Authors:  M J Blok; I Lautenschlager; V J Goossens; J M Middeldorp; C Vink; K Höckerstedt; C A Bruggeman
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

Review 6.  Infections after orthotopic liver transplantation.

Authors:  Mark Pedersen; Anil Seetharam
Journal:  J Clin Exp Hepatol       Date:  2014-07-24

7.  How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation.

Authors:  Hermann Einsele; Per Ljungman; Michael Boeckh
Journal:  Blood       Date:  2020-05-07       Impact factor: 22.113

8.  Management of deep Candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party.

Authors: 
Journal:  Intensive Care Med       Date:  1994-08       Impact factor: 17.440

9.  Pharmacokinetics of ganciclovir in pediatric renal transplant recipients.

Authors:  Daolun Zhang; Anne-Laure Lapeyraque; Michel Popon; Chantal Loirat; Evelyne Jacqz-Aigrain
Journal:  Pediatr Nephrol       Date:  2003-07-23       Impact factor: 3.714

10.  Missed diagnosis and misdiagnosis of infectious diseases in hematopoietic cell transplant recipients: an autopsy study.

Authors:  Ashrit Multani; Libby S Allard; Tamna Wangjam; R Alejandro Sica; David J Epstein; Andrew R Rezvani; Dora Y Ho
Journal:  Blood Adv       Date:  2019-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.